Birth Defects Res by Louden, Adia R. et al.
Association between maternal periconceptional alcohol 
consumption and neural tube defects: Findings from the 
National Birth Defects Prevention Study, 1997–2011
Adia R. Louden1,a, Jonathan Suhl2,a, Vijaya Kancherla1, Kristin M. Conway2, Jennifer 
Makelarski3, Meredith M. Howley4, Adrienne T. Hoyt5, Richard S. Olney6, Andrew F. 
Olshan7, Paul A. Romitti2, National Birth Defects Prevention Study
1Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, Georgia
2Department of Epidemiology, College of Public Health, The University of Iowa, Iowa City, Iowa
3Department of Obstetrics and Gynecology, University of Chicago, Chicago, Illinois
4Congenital Malformations Registry, New York State Department of Health, Albany, NY
5Department of Health and Human Performance, University of Houston, Houston, Texas
6Genetic Disease Screening Program, California Department of Public Health, Richmond, 
California
7Department of Epidemiology, Gillings School of Global Public Health, University of North 
Carolina, Chapel Hill, North Carolina
Abstract
Background—Neural tube defects (NTD)s are common birth defects with a multifactorial 
etiology. Findings from human studies examining environmental (non-inherited) exposures tend to 
be inconclusive. In particular, although animal studies of alcohol exposure and NTDs support its 
teratogenic potential, human studies are equivocal. Using data from the National Birth Defects 
Prevention Study (NBDPS), associations between maternal periconceptional (one month before 
through one month after conception) alcohol consumption and NTDs in offspring were examined.
Methods—NTD cases and unaffected live born singleton controls with expected dates of delivery 
from October 1997–December 2011 were enrolled in the NBDPS. Interview reports of alcohol 
consumption (quantity, frequency, variability, type) from 1,922 case and 11,251 control mothers 
were analyzed. Crude and adjusted odds ratios (aOR)s and 95% confidence intervals (CI)s for 
alcohol consumption and all NTDs combined and selected subtypes (spina bifida, anencephaly, 
encephalocele) were estimated using unconditional logistic regression analysis.
Results—Among mothers in the NBDPS, 28% of NTD case and 35% of control mothers 
reported any periconceptional alcohol consumption. For each measure of alcohol consumption, 
inverse associations were observed for all NTDs combined (aORs=0.6–1.0). Results for NTD 
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subtypes tended to be similar, but CIs for spina bifida and encephalocele were more likely to 
include the null.
Conclusions—These findings suggest a lack of positive associations between maternal 
periconceptional alcohol consumption and NTDs. Future studies should continue to evaluate the 
association between maternal alcohol consumption and NTDs in offspring accounting for 
methodological limitations such as potential misclassification from self-reported alcohol 
consumption.
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1 | INTRODUCTION
Neural tube defects (NTDs) are major birth defects of the central nervous system 
characterized by incomplete closure of the neural tube (reviewed in Botto, Moore, Khoury, 
& Erickson, 1999). In the United States (US), approximately 2,800 pregnancies are affected 
by NTDs annually, with an estimated birth prevalence of approximately 7 per 10,000 live 
births (Williams et al., 2015). The two most common NTD subtypes are anencephaly and 
spina bifida, which affect the brain and spinal cord, respectively (Greene & Copp, 2014). 
Due to its severity, pregnancies affected by anencephaly often result in stillbirth or elective 
termination (Blencowe, Kancherla, Moorthie, Darlison, & Modell, 2018); survival of live 
born infants ranges from a few hours to days (Baird & Sadovnick, 1984). Pregnancies 
affected by spina bifida also may result in stillbirth or elective termination (Blencowe et al., 
2018), and live born infants with spina bifida may have many health complications and life-
long disability that includes varying degrees of paralysis (Sawin et al., 2015). The average 
lifetime cost of care per child with spina bifida, including caregiving costs, is estimated to be 
approximately US$ 790,000 (Grosse, Berry, Tilford, Kucik, & Waitzman, 2016).
NTDs are considered to have a multifactorial etiology, with previous studies reporting 
associations with genetic variants and environmental (non-inherited) exposures (reviewed in 
Greene & Copp, 2014). Aside from genetic factors, early studies identified maternal folic 
acid supplementation as a significant protective factor in NTD occurrence (reviewed in 
Viswanathan et al., 2017). Several other environmental exposures have been associated with 
an increased risk of NTDs, such as maternal diabetes (Correa et al., 2008), pre-pregnancy 
obesity (Huang, Chen, & Feng, 2017), and use of certain medications during early 
pregnancy (Brender et al., 2011; Jentink et al., 2010; Mitchell, 2005; Yazdy, Mitchell, 
Tinker, Parker, & Werler, 2013).
Maternal alcohol consumption during pregnancy is among the environmental exposures that 
may potentially increase the risk of NTDs. Animal studies have reported NTDs following 
administration of alcohol to pregnant animals (reviewed in Aronne, Evrard, Mirochnic, & 
Brusco, 2008; Becker, Diaz-Granados, & Randall, 1996). However, human studies 
examining early pregnancy alcohol consumption (defined as the number of alcoholic drinks 
consumed per day, week, or month) have mostly reported null or modestly positive 
associations with all NTDs combined (Grewal, Carmichael, Ma, Lammer, & Shaw, 2008; 
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McDonald, Armstrong, & Sloan, 1992; Shaw, Velie, & Morland, 1996; Suarez, Felkner, 
Brender, Canfield, & Hendricks, 2007) and some NTD subtypes (Benedum, Yazdy, Mitchell, 
& Werler, 2013; De Marco et al., 2011; Grewal et al., 2008). Also, associations generally 
near or below unity have been reported for associations between early pregnancy binge 
drinking and all NTDs combined (Grewal et al., 2008; Shaw et al., 1996; Suarez et al., 2007) 
and NTD subtypes (Benedum et al., 2013; Grewal et al., 2008). Most of these previous 
studies, however, were limited by the inability to examine NTD subtypes, which is important 
due to developmental and etiologic heterogeneity in NTD development (reviewed in 
Mitchell, 2005) and the lack of specificity in alcohol exposure measures (e.g. inability to 
examine type of alcohol consumed).
To address the limitations of these studies, an analysis using National Birth Defects 
Prevention Study (NBDPS) data from 1997–2005 examined associations between maternal 
alcohol exposure during the period from one month before conception (B1) through the 
second month of pregnancy and all NTDs combined and NTD subtypes; associations 
reported were mostly near unity (Makelarski et al., 2013). Since these analyses, an 
additional six years of data (2006–2011) were collected. The current study used the full 
NBDPS dataset (1997–2011) to examine associations between maternal alcohol exposure 
and all NTDs combined and selected NTD subtypes. These expanded data represent a 
substantially larger sample of NTD cases than previous studies and examined a more 
restricted period of periconceptional exposure (B1 through the month following conception 
[P1]), which more closely corresponds with the critical period of neural tube development.
2 | METHODS
2.1 | The National Birth Defects Prevention Study
The NBDPS, a population-based, multisite case-control study conducted in the US, was 
designed to study genetic and environmental (broadly defined) factors for major structural 
birth defects. Methods for the NBDPS are detailed elsewhere (Reefhuis et al., 2015). Briefly, 
the NBDPS included cases and controls with estimated dates of deliveries (EDD)s from 
October 1, 1997-December 31, 2011 identified by 10 birth defect surveillance programs 
(Arkansas, California, Georgia, Iowa, Massachusetts, New Jersey, New York, North 
Carolina, Texas, Utah) (Reefhuis et al., 2015). Eligible cases were live births (all sites), fetal 
deaths at 20 weeks or greater gestation (six sites), and elective terminations (five sites); 
eligible controls were non-malformed, singleton live births. Case or control children were 
excluded from the NBDPS if their mother had participated in the study with a previous 
pregnancy, could not complete the interview in English or Spanish, or was incarcerated or 
otherwise did not have legal custody of their child at the time of the interview (Reefhuis et 
al., 2015). Maternal interviews were conducted between six weeks and 24 months following 
their EDD and collected data on maternal exposures, including infectious, chemical, 
physical, nutritional, and behavioral exposures (Reefhuis et al., 2015).
2.2 | Case enumeration and classification
NTD cases (modified British Paediatric Association diagnostic code) included in the 
NBDPS were anencephaly (including craniorachischisis; 740.020, 740.100), spina bifida 
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(741.000–741.990), and encephalocele (including cranial meningocele and 
encephalomyelocele; 742.000–742.090) (Rasmussen et al., 2003). Diagnosis of an NTD was 
confirmed using standardized criteria and clinical geneticist review of clinical data 
abstracted from medical records (Rasmussen et al., 2003). Clinical geneticists classified 
cases as isolated (no additional major defects or one or more additional major defects 
developmentally related to an NTD), multiple (one or more additional major defects in 
different organ systems), or complex (pattern of major defects embryologically related and 
likely to represent an early problem in morphogenesis). Cases with a known chromosomal 
defect or monogenetic disorder were excluded (Rasmussen et al., 2003).
2.3 | Control Selection
Control children – non-malformed live births delivered during the same time period and in 
the same geographic region as case children – were randomly selected from birth certificates 
or hospital records (Reefhuis et al., 2015).
2.4 | Exposure Assessment
Mothers were asked in the NBDPS interview if they drank alcohol any time during the three 
months before conception through the end of pregnancy. If mothers reported alcohol 
consumption, they were asked about the month(s) during which they drank (yes, no), 
average number of drinking days in a drinking month (frequency), average number of drinks 
per drinking day in each drinking month, greatest number of drinks on one occasion per 
drinking month (variability), and types of alcohol consumed (beer, wine, and/or distilled 
spirits). These data were used to assign maternal alcohol consumption during the 
periconceptional period (B1-P1) using an approach that was previously developed for the 
NBDPS (Romitti et al., 2007). Specifically, the average number of drinks per drinking 
month was calculated by multiplying the average number of drinking days by the average 
number of drinks per drinking day for the specified month. The average number of drinks in 
the periconceptional period was calculated using the average number of drinks per month 
(B1, P1, both) divided by the number of months a mother drank (B1, P1, both). The 
maximum average number of drinks per month also was calculated using the highest 
reported average number of drinks per month (B1 or P1) divided by the number of months a 
mother drank during the periconceptional period (B1, P1, both).
Four categories were used to classify reported periconceptional alcohol consumption using a 
30-day month: monthly to weekly (1–4 drinks per month); weekly to every other day (5–15 
drinks per month); every other day to daily (16–30 drinks per month); and daily with more 
than one drink per day (>30 drinks per month). Binge episodes were estimated using sex-
specific norms for females of four or more drinks per day on average, on one occasion, or 
both (Wechsler, Dowdall, Davenport, & Rimm, 1995). To categorize binge episodes, case 
and control mothers were classified as those who reported: no consumption; consumption 
without any binge episodes; or one or more binge episodes. Additionally, mothers were 
classified by type of alcohol consumed as: beer only; wine only; distilled spirits only; or any 
combination of two or more types of alcohol.
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2.5 | Covariates
Child covariates examined were sex (male, female), first-degree family history of NTDs 
(yes, no), and NBDPS site (Arkansas, California, Georgia, Iowa, Massachusetts, New Jersey, 
New York, North Carolina, Texas, Utah). Maternal covariates examined were race/ethnicity 
(non-Hispanic white, non-Hispanic black, Hispanic, other), age at delivery (<20, 20–34, ≥35 
years), education at delivery (less than high school, high school graduate, some college or 
higher), pre-pregnancy body mass index (BMI) (underweight [<18.5], normal [18.5–24.9], 
overweight [25–29.9], obese [≥30] kg/m2), gravidity (0, 1–2, ≥3), pregnancy intention 
(intended, mistimed, ambivalent, unwanted), pre-pregnancy hypertension (yes, no), pre-
pregnancy daily caffeine intake (0–9, 10–99, 100–199, 200–299, ≥300 mg/day), and 
periconceptional cigarette smoke exposure (no active or passive smoking, active only, 
passive only, active and passive).
Periconceptional use of folic acid-containing supplements (yes, no) also was examined as a 
covariate. Vitamin and supplement use three months before conception through end of 
pregnancy was collected in the NBDPS interview. For each vitamin or supplement reported, 
mothers were asked to provide start and stop dates (or duration of use if dates were 
unknown) and frequency of use. Each reported supplement was assessed to determine 
whether it contained folic acid. Additionally, pre-pregnancy dietary folate intake (<600, 
≥600 μg/day) was examined using responses from the dietary module of the NBDPS 
interview. The Willet Food Frequency questionnaire (Willett, Reynolds, Cottrell-Hoehner, 
Sampson, & Browne, 1987; Willett et al., 1985) was adapted for the NBDPS interview and 
measured food intake during the year before conception, along with reports of breakfast 
cereals consumed during P1. Reported food frequencies, standardized serving size, and US 
Department of Agriculture National Standard Reference 16–1 (United States Department of 
Agriculture, 2004) were used to estimate dietary folate equivalents (DFEs).
2.6 | Exclusions
Case and control mothers with an unknown or missing response to the question regarding 
alcohol consumption any time during the three months before through the end of pregnancy 
and those with a monthly average consumption estimate of 120 drinks or more were 
excluded from analyses. Also excluded were children classified as a complex case, mothers 
who had reported pre-pregnancy diabetes, and those with unknown or reported use of folate 
antagonist medications (aminopterin sodium, carbamazepine, cholestyramine resin, 
methotrexate, oxcarbazepine, pyrimethamine, sulfasalazine, triamterene, trimethoprim, 
phenytoin, primidone, phenobarbital, valproate sodium) during the periconceptional period.
2.7 | Statistical Analysis
Descriptive analyses used the chi-square test of independence to compare child and maternal 
covariates between cases and controls. Unconditional logistic regression analysis was used 
to estimate crude and adjusted odds ratios and their respective 95% confidence intervals 
(CI)s for associations between different categories of maternal alcohol consumption (any, 
binge episodes, average drinks per month, maximum drinks per month, type of alcohol) and 
all NTDs and NTD subtypes. Variables that differed statistically (p<0.05) between controls 
and all NTD cases combined in descriptive analyses were considered for adjusted models 
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(Table 1). Covariates in adjusted models were selected using a change-in-estimate approach. 
For each exposure-outcome pairing, individual covariates were entered into a model 
containing the alcohol exposure variable of interest. Covariates that altered the main effect 
by >10% were retained in the final model. Adjusted odds ratios and 95% CIs were estimated 
using models that contained all covariates for which the 10% change-in-estimate criteria was 
met for the respective exposure-outcome pair.
Several subanalyses were conducted, as data permitted. To evaluate the representativeness of 
the analytic sample following exclusions, we compared the distributions of covariates for 
NTD cases and controls in the analytic sample to those for all NBDPS NTD cases and 
controls prior to exclusions using the chi-square goodness-of-fit test. Subanalyses compared 
isolated NTD cases and controls, as there may be etiologic differences between isolated and 
multiple cases. Subanalyses also compared consumption patterns stratified by type of 
alcohol (beer only, wine only, distilled spirits only, any combination of alcohol) because 
some previous studies suggested beer consumption may increase red blood cell folate and 
plasma 5-methyltetrahydrofolic acid concentrations (Larroque et al., 1992; Stark et al., 
2005). Additionally, interactions between alcohol exposure (any, binge episodes) and folate 
status were tested. A dichotomous variable was created by combining responses for use of 
folic acid supplements and dietary folate intake. Mothers who reported no use of folic acid-
containing supplements and pre-pregnancy dietary folate intake <600μg/day were 
considered folate deficient, whereas those reporting either use of folic-acid containing 
supplements and/or pre-pregnancy dietary folate intake ≥600 μg/day were considered to 
have sufficient folate levels. The statistical significance of multiplicative interaction was 
determined using p-values, and the significance of additive interaction estimates (relative 
excess risk due to interaction) was determined using bootstrap 95% CIs (Knol, van der 
Tweel, Grobbee, Numans, & Geerlings, 2007). The relative excess risk due to interaction 
and bootstrap 95% CIs were estimated using a SAS program created by Sandra Richardson, 
RN, MS (personal communication, New York State Department of Health, 2011). To 
examine the potential for exposure misclassification, analyses were stratified by pregnancy 
intention and, also, by time between EDD and date of the NBDPS interview (0–6, 7–12, 13–
18, >18 months). All analyses were conducted using the Statistical Analysis System (SAS) 
version 9.4 statistical software (SAS Institute Inc., 2013).
3 | RESULTS
Overall, 2,191 NTD cases and 11,829 controls were enrolled in the NBDPS. Among these 
mothers, 2,152 case and 11,626 control mothers completed the alcohol module of the 
NBDPS interview. Of the mothers who provided information on periconceptional alcohol 
consumption, 230 case and 375 control mothers were excluded due to: complex NTD cases 
(cases=3), maternal pre-pregnancy diabetes (cases=47; controls=82), reported or unknown 
maternal periconceptional exposure to folic acid antagonist medications (cases=39; 
controls=180), an unknown or missing response for alcohol consumption any time during 
the three months before through the end of pregnancy (cases=129, controls=69), or reported 
average monthly consumption estimate of ≥120 drinks (cases=12, controls=44). A total of 
1,922 (88% of total) cases (anencephaly=541, spina bifida=1,173, encephalocele=208) and 
11,251 controls (95% of total) remained in the final analytic sample.
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Among all NTD cases, 87.5% were isolated, with a lower proportion of encephalocele cases 
classified as isolated compared to anencephaly and spina bifida (Table 1). Statistical 
differences (p<0.05) were observed between all NTDs combined and controls for first-
degree family history of NTDs, NBDPS site, and maternal race/ethnicity, education at 
delivery, pre-pregnancy BMI, gravidity, periconceptional use of folic acid-containing 
supplements, pre-pregnancy daily folate intake, pregnancy intention, pre-pregnancy 
hypertension, pre-pregnancy caffeine intake, and periconceptional cigarette smoke exposure 
(Table 1). Statistical differences were observed between NTD subtypes and controls for 
child sex (anencephaly), first-degree family history of NTDs (spina bifida, encephalocele), 
and NBDPS site (anencephaly, spina bifida), along with maternal race/ethnicity 
(anencephaly, spina bifida, encephalocele), education at delivery (anencephaly, spina bifida), 
pre-pregnancy BMI (spina bifida), gravidity (anencephaly, spina bifida), pregnancy intention 
(spina bifida), periconceptional use of folic acid-containing supplements (encephalocele), 
pre-pregnancy hypertension (anencephaly) and periconceptional cigarette smoke exposure 
(anencephaly, spina bifida, encephalocele) (Table 1).
Overall, 27.5% of NTD case mothers and 35.4% of control mothers reported any 
periconceptional alcohol consumption (Table 2). The proportion of mothers reporting 
alcohol consumption during B1 only or B1+P1 was greater for mothers of controls than all 
NTDs combined; a similar proportion of NTD case and control mothers reported 
consumption during P1 only. Overall, mothers of cases and controls most frequently 
reported consumption of any combination of alcohol types. Proportions of NTD case and 
control mothers that reported consuming beer or distilled spirits (either alone or in 
combination) tended to be similar; however, a greater proportion of control mothers reported 
consuming wine only compared to case mothers. Among NTD subtypes, patterns of 
maternal periconceptional alcohol consumption tended to be similar to those for mothers of 
all NTDs combined.
Inverse associations were observed for any periconceptional consumption, consumption with 
and without binge episodes, all levels of periconceptional average number of drinks per 
month, and most types of alcohol for all NTDs combined; most CIs for these associations 
excluded the null (Table 3). Similar results were observed when using maximum average 
number of drinks per month (data not shown). Associations for each NTD subtype tended to 
be similar to those estimated for all NTDs combined; however, the CIs for spina bifida and 
encephalocele were more likely to include the null.
Results of subanalyses comparing the distributions of covariates for all NTD cases and 
controls prior to study exclusions was not materially different from the distributions of 
covariates in the analytic sample following exclusions (data not shown). Results examining 
only isolated cases were generally similar to their respective main analyses (data not shown), 
as were results for consumption patterns stratified by type of alcohol consumed (data not 
shown). Also, results of association analyses stratified by pregnancy intention tended to be 
similar to the respective main analyses, except for associations for spina bifida among 
mothers with unwanted pregnancies, where most aORs were greater than 1.5 (aORs=0.8–
3.4). Additionally, no statistically significant multiplicative or additive interaction for 
alcohol consumption (any or binge episodes) and folate status were observed (data not 
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shown). Lastly, although case mothers more frequently completed the NBDPS interview 12 
months or later after the child’s EDD than control mothers, results of association analyses 
stratified by time to interview were not materially different than the respective main analyses 
(data not shown).
4 | DISCUSSION
The current study used data from the NBDPS, which improved upon the methodology of 
previous studies by examining several measures of alcohol exposure during a more restricted 
period (B1-P1) of neural tube development. Additionally, the NBDPS included over 2,000 
NTD cases and 11,000 controls, making it the largest study of maternal alcohol consumption 
during pregnancy and NTDs. Observed associations with any periconceptional alcohol 
consumption, binge episodes, average and maximum number of drinks per month, and type 
of alcohol consumed were near or below unity for all NTDs combined. The findings for 
NTD subtypes generally paralleled those for all NTDs combined, although CIs for spina 
bifida and encephalocele more frequently included the null. The lack of positive associations 
observed is comparable with findings of most previous studies that examined any maternal 
alcohol consumption (Benedum et al., 2013; Grewal et al., 2008; McDonald et al., 1992; 
Shaw et al., 1996; Suarez et al., 2007) or binge drinking (Benedum et al., 2013; Grewal et 
al., 2008; Shaw et al., 1996; Suarez et al., 2007) and NTDs. Additionally, the results were 
similar to those of the previous NBDPS study using data from 1997–2005 (Makelarski et al., 
2013).
Although animal models suggest associations between administration of alcohol to pregnant 
animals and NTDs in offspring (reviewed in Aronne et al., 2008; Becker et al., 1996), and 
several biologically plausible mechanisms have been proposed (Bannigan & Burke, 1982; 
Kotch & Sulik, 1992; Liu, Balaraman, Wang, Nephew, & Zhou, 2009; McMartin, 1984; 
Muldoon & McMartin, 1994), these results have not translated to human studies. The 
disparity in positive results between animal studies and the current study could be due to 
methodological differences between animal and human studies and the limitations inherent 
to epidemiologic designs. In particular, the alcohol dose of exposure in animal studies are 
often designed to produce teratogenic effects (e.g. animal dosing generally exceeds the level 
of consumption in humans). In the current study, only a small proportion of mothers 
reported heavy drinking, which may contribute to the observed null findings. The timing of 
exposure in animal studies also is typically very precise. Conversely, human studies rely on 
maternal recall to assign alcohol dose and determine exposure timing; inaccurate recall 
could result in exposure misclassification, potentially biasing results. However, a previous 
study that examined the potential for misclassification of maternal alcohol consumption 
during pregnancy did not find statistical differences between prospective and retrospective 
recall of consumption suggesting minimal recall bias (Verkerk, Buitendijk, & Verloove-
Vanhorick, 1994). Also, results of our subanalyses examining the influence of time to 
NBDPS interview on recall of alcohol consumption were not materially different than results 
from the main analyses. Another source of potential exposure misclassification in human 
studies may be under-reporting of alcohol consumption due to the stigma associated with 
alcohol consumption during pregnancy. In the current study, control mothers more 
frequently reported alcohol consumption than case mothers, suggesting underreporting 
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among case mothers. However, the percentages of case and control mothers who reported 
any alcohol consumption in this study exceeded national estimates suggesting minimal bias 
due to underreporting (Denny, Acero, Naimi, & Kim, 2019).
An alternative explanation for the lack of positive associations could be that there is no 
positive association between low to moderate alcohol consumption and NTDs in humans, as 
suggested by the general consistency of studies. More likely, pregnancy intention may 
influence risk, as subanalyses suggested that for mothers of children with unwanted 
pregnancies, alcohol consumption was associated with increased risk of delivering a child 
with spina bifida. Also, with the number of statistical comparisons generated, some of the 
inverse associations with CIs that excluded the null may have been due to chance. Another 
explanation is that maternal alcohol consumption has been associated with early pregnancy 
loss (Henriksen et al., 2004) and could lead to survival bias (Khoury, James, Flanders, & 
Erickson, 1992). Early pregnancy loss (prior to 20 weeks gestation) was not able to be 
ascertained comprehensively in the NBDPS. An additional explanation may be the impact of 
prenatal alcohol consumption on genes involved in neural development and folate 
metabolism, which were not explored in the current study. For example, Wnt signaling is 
involved in vertebrate neural development (Mulligan & Cheyette, 2012) and folate 
metabolism (Gray et al., 2010). In particular, ethanol has been shown to suppress Wnt 
signaling proteins, including those involved in differentiating human neural stem cells 
(Vangipuram & Lyman, 2012).
Despite the limitations in alcohol exposure assessment, the current study had several 
strengths. NBDPS data provided a large, multisite population-based sample, minimizing the 
potential for selection bias. A study comparing maternal characteristics of controls to all live 
births at each site reported that NBDPS controls are similar to all live births on several 
maternal characteristics (Cogswell et al., 2009). The NBDPS included live births, fetal 
deaths of ≥20 weeks gestation, and elective terminations, helping to reduce potential biases 
related to case ascertainment, and diagnoses were confirmed by clinical geneticists, 
minimizing outcome misclassification. Also, the current study was able to evaluate 
associations between maternal alcohol consumption and NTD subtypes, which is important 
due to the heterogeneity of NTDs. Additionally, mothers who reported risk factors that are 
known to be strongly associated with the development of NTDs in offspring, such as pre-
pregnancy diabetes or use of folate-antagonist medication, were excluded from analyses. 
Lastly, the NBDPS collected detailed information on alcohol consumption during pregnancy, 
allowing for the examination of alcohol consumption in multiple ways, including by alcohol 
type, which has not been evaluated in non-NBDPS studies.
In conclusion, this study used a large, population-based sample to examine associations 
between maternal periconceptional alcohol exposure and NTDs in offspring. Results for any 
maternal consumption, binge episodes, average and maximum number of drinks, and type of 
alcohol consumed were largely near or below unity for all NTDs combined and NTD 
subtypes. Even with biologically plausible mechanisms proposed from animal models, few 
positive associations between maternal alcohol consumption in early pregnancy and NTDs 
have been observed to date. This discordance may be due to limitations in human studies. 
Future studies should attempt to improve upon our study by increasing sample size, 
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particularly for rarer NTD subtypes, refining exposure classifications, including stratification 
of alcohol types and more precise consumption estimates, improving ascertainment of 
pregnancies ending in early fetal loss, and explore genomic contributions of alcohol 
exposure to NTD development.
ACKNOWLEDGMENTS
We gratefully acknowledge the NBDPS study participants and the sites that contributed NBDPS data to this study: 
Arkansas, California, Georgia, Massachusetts, New Jersey, New York, North Carolina, Texas, and Utah. The 
findings and conclusions in this report are those of the authors and do not necessarily represent the official views of 
the Centers for Disease Control and Prevention, the U.S. Department of Health and Human Services, or California 
Department of Public Health.
Funding: This publication was supported by funding from the Centers for Disease Control and Prevention (CDC) 
cooperative agreements under PA #96043, PA #02081, FOA #DD09-001, FOA #DD13-003, and NOFO 
#DD18-001 to the Centers for Birth Defects Research and Prevention participating in the National Birth Defects 
Prevention Study (NBDPS) and/or the Birth Defects Study To Evaluate Pregnancy exposureS (BD-STEPS) and the 
Iowa Center for Birth Defects Research and Prevention U01 DD001035 and U01 DD001223 (P.A.R.). The findings 
and conclusions in this report are those of the authors and do not necessarily represent the official views of the CDC 
or the Department of Health and Human Services.
REFERENCES
Aronne MP, Evrard SG, Mirochnic S, & Brusco A (2008). Prenatal Ethanol Exposure Reduces the 
Expression of the Transcriptional FactorPax6in the Developing Rat Brain. Annals of the New York 
Academy of Sciences, 1139(1), 478–498 [PubMed: 18991895] 
Baird PA, & Sadovnick AD (1984). Survival in infants with anencephaly. Clin Pediatr (Phila), 23(5), 
268–271 [PubMed: 6705433] 
Bannigan J, & Burke P (1982). Ethanol teratogenicity in mice: A light microscopic study. Teratology, 
26(3), 247–254 [PubMed: 7163973] 
Becker HC, Diaz-Granados JL, & Randall CL (1996). Teratogenic actions of ethanol in the mouse: A 
minireview. Pharmacology Biochemistry and Behavior, 55(4), 501–513
Benedum C, Yazdy M, Mitchell A, & Werler M (2013). Risk of Spina Bifida and Maternal Cigarette, 
Alcohol, and Coffee Use during the First Month of Pregnancy. International Journal of 
Environmental Research and Public Health, 10(8), 3263–3281 [PubMed: 23917813] 
Blencowe H, Kancherla V, Moorthie S, Darlison MW, & Modell B (2018). Estimates of global and 
regional prevalence of neural tube defects for 2015: a systematic analysis. Annals of the New York 
Academy of Sciences, 1414(1), 31–46 [PubMed: 29363759] 
Botto LD, Moore CA, Khoury MJ, & Erickson JD (1999). Neural-Tube Defects. New England Journal 
of Medicine, 341(20), 1509–1519 [PubMed: 10559453] 
Brender JD, Werler MM, Kelley KE, Vuong AM, Shinde MU, Zheng Q,… The National Birth Defects 
Prevention, S. (2011). Nitrosatable drug exposure during early pregnancy and neural tube defects in 
offspring: National Birth Defects Prevention Study. Am J Epidemiol, 174(11), 1286–1295 
[PubMed: 22047825] 
Cogswell ME, Bitsko RH, Anderka M, Caton AR, Feldkamp ML, Sherlock SMH,… Reefhuis J 
(2009). Control Selection and Participation in an Ongoing, Population-based, Case-Control Study of 
Birth Defects. American Journal of Epidemiology, 170(8), 975–985 [PubMed: 19736223] 
Correa A, Gilboa SM, Besser LM, Botto LD, Moore CA, Hobbs CA,… Reece EA (2008). Diabetes 
mellitus and birth defects. Am J Obstet Gynecol, 199(3), 237 e231–239 [PubMed: 18674752] 
De Marco P, Merello E, Calevo MG, Mascelli S, Pastorino D, Crocetti L,… Capra V (2011). Maternal 
periconceptional factors affect the risk of spina bifida-affected pregnancies: an Italian case–control 
study. Child’s Nervous System, 27(7), 1073–1081
Denny CH, Acero CS, Naimi TS, & Kim SY (2019). Consumption of Alcohol Beverages and Binge 
Drinking Among Pregnant Women Aged 18–44 Years - United States, 2015–2017. MMWR Morb 
Mortal Wkly Rep, 68(16), 365–368 [PubMed: 31022164] 
Louden et al. Page 10
Birth Defects Res. Author manuscript; available in PMC 2020 April 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Gray JD, Nakouzi G, Slowinska-Castaldo B, Dazard JE, Rao JS, Nadeau JH, & Ross ME (2010). 
Functional interactions between the LRP6 WNT co-receptor and folate supplementation. Hum Mol 
Genet, 19(23), 4560–4572 [PubMed: 20843827] 
Greene ND, & Copp AJ (2014). Neural tube defects. Annu Rev Neurosci, 37, 221–242 [PubMed: 
25032496] 
Grewal J, Carmichael SL, Ma C, Lammer EJ, & Shaw GM (2008). Maternal periconceptional smoking 
and alcohol consumption and risk for select congenital anomalies. Birth Defects Research Part A: 
Clinical and Molecular Teratology, 82(7), 519–526 [PubMed: 18481814] 
Grosse SD, Berry RJ, Tilford MJ, Kucik JE, & Waitzman NJ (2016). Retrospective Assessment of Cost 
Savings From Prevention: Folic Acid Fortification and Spina Bifida in the U.S. American Journal 
of Preventive Medicine, 50(5), S74–S80 [PubMed: 26790341] 
Henriksen TB, Hjollund NH, Jensen TK, Bonde JP, Andersson AM, Kolstad H,… Olsen J (2004). 
Alcohol consumption at the time of conception and spontaneous abortion. Am J Epidemiol, 
160(7), 661–667 [PubMed: 15383410] 
Huang HY, Chen HL, & Feng LP (2017). Maternal obesity and the risk of neural tube defects in 
offspring: A meta-analysis. Obes Res Clin Pract, 11(2), 188–197 [PubMed: 27155922] 
Jentink J, Loane MA, Dolk H, Barisic I, Garne E, Morris JK,… Group EASW (2010). Valproic acid 
monotherapy in pregnancy and major congenital malformations. N Engl J Med, 362(23), 2185–
2193 [PubMed: 20558369] 
Khoury MJ, James LM, Flanders WD, & Erickson JD (1992). Interpretation of recurring weak 
associations obtained from epidemiologic studies of suspected human teratogens. Teratology, 
46(1), 69–77 [PubMed: 1641813] 
Knol MJ, van der Tweel I, Grobbee DE, Numans ME, & Geerlings MI (2007). Estimating interaction 
on an additive scale between continuous determinants in a logistic regression model. Int J 
Epidemiol, 36(5), 1111–1118 [PubMed: 17726040] 
Kotch LE, & Sulik KK (1992). Experimental fetal alcohol syndrome: Proposed pathogenic basis for a 
variety of associated facial and brain anomalies. American Journal of Medical Genetics, 44(2), 
168–176 [PubMed: 1456286] 
Larroque B, Kaminski M, Lelong N, d’Herbomez M, Dehaene P, Querleu D, & Crepin G (1992). 
Folate status during pregnancy: relationship with alcohol consumption, other maternal risk factors 
and pregnancy outcome. Eur J Obstet Gynecol Reprod Biol, 43(1), 19–27 [PubMed: 1737604] 
Liu Y, Balaraman Y, Wang G, Nephew KP, & Zhou FC (2009). Alcohol exposure alters DNA 
methylation profiles in mouse embryos at early neurulation. Epigenetics, 4(7), 500–511 [PubMed: 
20009564] 
Makelarski JA, Romitti PA, Sun L, Burns TL, Druschel CM, Suarez L,… Olney RS (2013). 
Periconceptional maternal alcohol consumption and neural tube defects. Birth Defects Research 
Part A: Clinical and Molecular Teratology, 97(3), 152–160 [PubMed: 23456758] 
McDonald AD, Armstrong BG, & Sloan M (1992). Cigarette, alcohol, and coffee consumption and 
congenital defects. American Journal of Public Health, 82(1), 91–93 [PubMed: 1536342] 
McMartin KE (1984). Increased Urinary Folate Excretion and Decreased Plasma Folate Levels in the 
Rat after Acute Ethanol Treatment. Alcoholism: Clinical and Experimental Research, 8(2), 172–
178
Mitchell LE (2005). Epidemiology of neural tube defects. American Journal of Medical Genetics Part 
C: Seminars in Medical Genetics, 135C(1), 88–94
Muldoon RT, & McMartin KE (1994). Ethanol Acutely Impairs the Renal Conservation of 5-
Methyltetrahydrofolate in the Isolated Perfused Rat Kidney. Alcoholism: Clinical and 
Experimental Research, 18(2), 333–339
Mulligan KA, & Cheyette BN (2012). Wnt signaling in vertebrate neural development and function. J 
Neuroimmune Pharmacol, 7(4), 774–787 [PubMed: 23015196] 
Rasmussen SA, Olney RS, Holmes LB, Lin AE, Keppler-Noreuil KM, & Moore CA (2003). 
Guidelines for case classification for the national birth defects prevention study. Birth Defects 
Research Part A: Clinical and Molecular Teratology, 67(3), 193–201 [PubMed: 12797461] 
Louden et al. Page 11
Birth Defects Res. Author manuscript; available in PMC 2020 April 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Reefhuis J, Gilboa SM, Anderka M, Browne ML, Feldkamp ML, Hobbs CA,… Honein MA (2015). 
The national birth defects prevention study: A review of the methods. Birth Defects Research Part 
A: Clinical and Molecular Teratology, 103(8), 656–669 [PubMed: 26033852] 
Romitti PA, Sun L, Honein MA, Reefhuis J, Correa A, & Rasmussen SA (2007). Maternal 
Periconceptional Alcohol Consumption and Risk of Orofacial Clefts. American Journal of 
Epidemiology, 166(7), 775–785 [PubMed: 17609516] 
SAS Institute Inc. (2013). SAS 9.4 (Version 9.4). Cary, NC: SAS Institute Inc.
Sawin KJ, Liu T, Ward E, Thibadeau J, Schechter MS, Soe MM, & Walker W (2015). The National 
Spina Bifida Patient Registry: Profile of a Large Cohort of Participants from the First 10 Clinics. 
The Journal of Pediatrics, 166(2), 444–450.e441 [PubMed: 25444012] 
Shaw GM, Velie EM, & Morland KB (1996). Parental Recreational Drug Use and Risk for Neural 
Tube Defects. American Journal of Epidemiology, 144(12), 1155–1160 [PubMed: 8956628] 
Stark KD, Pawlosky RJ, Beblo S, Murthy M, Flanagan VP, Janisse J,… Salem N Jr. (2005). Status of 
plasma folate after folic acid fortification of the food supply in pregnant African American women 
and the influences of diet, smoking, and alcohol consumption. Am J Clin Nutr, 81(3), 669–677 
[PubMed: 15755838] 
Suarez L, Felkner M, Brender JD, Canfield M, & Hendricks K (2007). Maternal Exposures to 
Cigarette Smoke, Alcohol, and Street Drugs and Neural Tube Defect Occurrence in Offspring. 
Maternal and Child Health Journal, 12(3), 394–401 [PubMed: 17641961] 
United States Department of Agriculture. (2004). USDA National Nutrient Database for Standard 
Reference, release 16. Beltsville, MD
Vangipuram SD, & Lyman WD (2012). Ethanol affects differentiation-related pathways and suppresses 
Wnt signaling protein expression in human neural stem cells. Alcohol Clin Exp Res, 36(5), 788–
797 [PubMed: 22150777] 
Verkerk PH, Buitendijk SE, & Verloove-Vanhorick SP (1994). Differential Misclassification of 
Alcohol and Cigarette Consumption by Pregnancy Outcome. International Journal of 
Epidemiology, 23(6), 1218–1225 [PubMed: 7721524] 
Viswanathan M, Treiman KA, Kish-Doto J, Middleton JC, Coker-Schwimmer EJ, & Nicholson WK 
(2017). Folic Acid Supplementation for the Prevention of Neural Tube Defects: An Updated 
Evidence Report and Systematic Review for the US Preventive Services Task Force. JAMA, 
317(2), 190–203 [PubMed: 28097361] 
Wechsler H, Dowdall GW, Davenport A, & Rimm EB (1995). A gender-specific measure of binge 
drinking among college students. American Journal of Public Health, 85(7), 982–985 [PubMed: 
7604925] 
Willett WC, Reynolds RD, Cottrell-Hoehner S, Sampson L, & Browne ML (1987). Validation of a 
semi-quantitative food frequency questionnaire: comparison with a 1-year diet record. J Am Diet 
Assoc, 87(1), 43–47 [PubMed: 3794132] 
Willett WC, Sampson L, Stampfer MJ, Rosner B, Bain C, Witschi J,… Speizer FE (1985). 
REPRODUCIBILITY AND VALIDITY OF A SEMIQUANTITATIVE FOOD FREQUENCY 
QUESTIONNAIRE. American Journal of Epidemiology, 122(1), 51–65 [PubMed: 4014201] 
Williams J, Mai CT, Mulinare J, Isenburg J, Flood TJ, Ethen M,… Centers for Disease Control and 
Prevention. (2015). Updated estimates of neural tube defects prevented by mandatory folic Acid 
fortification - United States, 1995–2011. MMWR Morb Mortal Wkly Rep, 64(1), 1–5 [PubMed: 
25590678] 
Yazdy MM, Mitchell AA, Tinker SC, Parker SE, & Werler MM (2013). Periconceptional use of 
opioids and the risk of neural tube defects. Obstet Gynecol, 122(4), 838–844 [PubMed: 24084542] 
Louden et al. Page 12
Birth Defects Res. Author manuscript; available in PMC 2020 April 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Louden et al. Page 13
Table 1.
Characteristics of control and case infants and birth mothers, National Birth Defects Prevention Study, 1997–
2011
Characteristic
Controls (n= 
11,251)
All NTDs 
Combined 
(n=1,922)
Anencephalya 
(n=541)
Spina Bifida 
(n=1,173) Encephalocele
b 
(n=208)
N % N % N % N % N %
Child
Phenotype
 Isolated NA NA 1,682 87.5 485 89.7 1,044 89.0 153 73.6
 Multiple NA NA 240 12.5 56 10.4 129 11.0 55 26.4
Sexc
 Male 5,718 50.9 917 49.3 222 45.7 599 51.2 96 47.1
 Female 5,523 49.1 931 50.7 265 54.3 559 48.8 107 52.9
 Missing 10 74 54 15 5
First-degree family history 
of NTDsd,e,f
 Yes 21 0.2 23 1.2 3 0.6 16 1.4 4 1.9
 No 11,230 99.8 1,899 98.8 538 99.5 1,157 98.6 204 98.1
 Missing 0 0 0 0 0
NBDPS sitec,d,e
 Arkansas 1,410 12.5 240 12.5 69 12.8 143 12.2 28 13.5
 California 1,214 10.8 366 19.0 122 22.6 214 18.2 30 14.4
 Georgia 1,208 10.7 236 12.3 65 12.0 142 12.1 29 13.9
 Iowa 1,240 11.0 200 10.4 46 8.5 135 11.5 19 9.1
 Massachusetts 1,366 12.1 104 5.4 21 3.9 71 6.1 12 5.8
 New Jersey 562 5.0 67 3.5 10 1.9 49 4.2 8 3.9
 New York 932 8.3 100 5.2 14 2.6 72 6.1 14 6.7
 Texas 1,282 11.4 234 12.2 78 14.4 133 11.3 23 11.1
 North Carolina 947 8.4 179 9.3 65 12.0 89 7.6 25 12.0
 Utah 1,090 9.7 196 10.2 51 9.4 125 10.7 20 9.6
Maternal
 Race/Ethnicityc,d,e,f
 Non-Hispanic white 6,558 58.3 967 50.3 255 47.1 627 53.5 85 40.9
 Non-Hispanic black 1,220 10.9 178 9.3 45 8.3 94 8.0 39 18.8
 Hispanic 2,735 24.3 655 34.1 201 37.2 387 33.0 67 32.2
 Other 736 6.5 122 6.4 40 7.4 65 5.5 17 8.2
 Missing 2 0 0 0 0
Age at delivery (years)
 <20 1,093 9.7 211 11.0 68 12.6 115 9.8 28 13.5
 20–34 8,577 76.2 1,454 75.7 409 75.6 896 76.4 149 71.6
 ≥35 1,581 14.1 257 13.4 64 11.8 162 13.8 31 14.9
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Characteristic
Controls (n= 
11,251)
All NTDs 
Combined 
(n=1,922)
Anencephalya 
(n=541)
Spina Bifida 
(n=1,173) Encephalocele
b 
(n=208)
N % N % N % N % N %
 Missing 0 0 0 0 0
 Education at delivery 
(years) c,d,e
 Less than high school 1,863 16.6 401 21.0 132 24.5 219 18.8 50 24.2
 High school graduate 2,650 23.6 528 27.6 145 26.9 320 27.4 63 30.4
 Some college or higher 6,696 59.7 983 51.4 262 48.6 627 53.8 94 45.4
 Missing 42 10 2 7 1
Pre-pregnancy BMI 
(kg/m2)d,e
 Underweight (<18.5) 578 5.4 71 4.0 26 5.1 39 3.6 6 3.1
 Normal weight (18.5–
24.9)
5,804 53.8 848 47.2 256 50.1 483 44.3 109 56.2
 Overweight (25- <30.0) 2,445 22.7 431 24.0 122 23.9 275 25.2 34 17.5
 Obese (≥30.0) 1,957 18.2 446 24.8 107 20.9 294 27.0 45 23.2
 Missing 467 126 30 82 14
 Gravidityc,d,e
 0 3,326 29.6 500 26.0 147 27.2 293 25.0 60 28.9
 1–2 5,459 48.5 914 47.6 241 44.6 576 49.2 97 46.6
 ≥3 2,464 21.9 507 26.4 153 28.3 303 25.9 51 24.5
 Missing 2 1 0 1 0
Pregnancy intentiond,e
 Intended 5,466 59.7 859 54.9 251 57.4 510 53.8 98 54.8
 Mistimed 1,848 20.2 330 21.1 82 18.8 211 22.3 37 20.7
 Ambivalent 1,035 11.3 231 14.8 59 13.5 148 15.6 24 13.4
 Unwanted 815 8.9 144 9.2 45 10.3 79 8.3 20 11.2
 Missing 2,087 358 104 225 29
Pre-pregnancy 
hypertensionc,d
 Yes 1,063 9.5 146 7.6 34 6.3 92 7.9 20 9.6
 No 10,161 90.5 1,773 92.4 507 93.7 1,078 92.1 188 90.4
 Missing 27 3 0 3
Caffeine intake (mg/
day)d,g
 0–9 2,051 18.3 304 15.9 94 17.5 183 15.7 27 13.2
 10–99 4,014 35.8 730 38.2 210 39.1 432 37.0 88 42.9
 100–199 2,575 23.0 473 24.8 132 24.6 294 25.2 47 22.9
 200–299 1,405 12.5 221 11.6 61 11.4 135 11.6 25 12.2
 ≥300 1,169 10.4 183 9.6 40 7.5 125 10.7 18 8.8
 Missing 37 11 4 4 3
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Characteristic
Controls (n= 
11,251)
All NTDs 
Combined 
(n=1,922)
Anencephalya 
(n=541)
Spina Bifida 
(n=1,173) Encephalocele
b 
(n=208)
N % N % N % N % N %
Cigarette smoke 
exposurec,d,e,f,h
 No Active or Passive 
Smoking
7,928 70.7 1,306 68.7 382 71.8 792 68.1 132 63.8
 Active Smoking Only 852 7.6 118 6.2 22 41 81 7.0 15 7.3
 Passive Smoking Only 1,326 11.8 311 16.4 96 18.1 175 15.1 40 19.3
 Active and Passive 
Smoking
1,105 9.9 167 8.8 32 6.0 115 9.9 20 9.7
 Missing 40 20 9 10 1
Use of folic acid-
containing 
supplementsd,f,h
 Yes 9,755 87.8 1,609 85.5 458 86.4 983 85.5 168 82.8
 No 1,356 12.2 274 14.6 72 13.6 167 14.5 35 17.2
 Missing 140 39 11 23 5
Daily folate intake (μg/
day)d,g
 <600 7,880 70.1 1,386 72.1 396 73.2 836 71.3 154 74.0
 ≥600 3,362 29.9 536 27.9 145 26.8 337 28.7 54 26.0
 Missing 9 0 0 0 0
BMI, body mass index; CDC, Centers for Disease Control and Prevention; kg, kilograms; mg, milligrams; NA, not applicable; NTD, neural tube 
defect; μg, micrograms.
Because of rounding, percentages may not total to 100.
a
Includes anencephaly and craniorachischisis cases.
b
Includes encephalocele, cranial meningocele, and encephalomyelocele cases.
cp<0.05 for anencephaly.
dp<0.05 for all NTDs combined.
ep<0.05 for spina bifida.
fp<0.05 for encephalocele.
g
During the year before conception.
h
During the periconceptional period (one month before conception through the first month of pregnancy).
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Table 2.
Reported patterns of maternal periconceptional alcohol consumption and type of alcohol consumed, National 
Birth Defects Prevention Study, 1997–2011
Periconceptional Alcohol 
Consumption
Controls 
(N=11,251)
All NTDs 
combined 
(N=1,922)
Anencephalya 
(N=541)
Spina Bifida 
(N=1,173) Encephalocele
b 
(N=208)
N % N % N % N % N %
Any consumption
 No 7,268 64.6 1,394 72.5 427 78.9 818 69.7 149 71.6
 Yes 3,983 35.4 528 27.5 114 21.1 355 30.3 59 28.4
Months
 B1 only 1,858 16.5 237 12.3 58 10.7 144 12.3 35 16.8
 B1+P1 1,713 15.2 216 11.2 40 7.4 157 13.4 19 9.1
 P1 only 412 3.7 75 3.9 16 3.0 54 4.6 5 2.4
Binge episodes
 None 7,268 64.9 1,394 72.8 427 79.2 818 70.3 149 71.6
 No binge episodes 2,625 23.4 327 17.1 70 13.0 215 18.4 42 20.2
 One or more binge 
episodes
1,312 11.7 194 10.1 42 7.8 135 11.6 19 8.2
 Missing 46 7 2 5 0
Average number of drinks 
per month
 0 7,268 65.0 1,394 72.9 427 79.2 818 70.2 149 71.6
 1–4 1,772 15.8 250 13.1 55 10.2 164 14.1 31 14.9
 5–15 1,348 12.1 178 9.3 32 5.9 128 11.0 18 8.7
 16–30 555 5.0 56 2.9 16 3.0 34 2.9 6 2.9
 >30 247 2.2 35 1.8 9 1.7 22 1.9 4 1.9
 Missing 61 9 2 7 0
Type of alcohol
 None 7,266 64.7 1,394 72.7 427 79.2 818 69.9 149 71.6
 Beer only 744 6.6 130 6.8 28 5.2 90 7.7 12 5.8
 Wine only 1,121 10.0 107 5.6 29 5.4 67 5.7 11 5.3
 Distilled spirits only 689 6.1 102 5.3 19 3.5 69 5.9 14 6.7
 Any combination 1,418 12.6 185 9.7 36 6.7 127 10.9 22 10.6
 Missing 13 4 2 2 0
B1, one month before conception; NTD, neural tube defect; P1, one month after conception.
a
Includes anencephaly and craniorachischisis cases.
b
Includes encephalocele, cranial meningocele, and encephalomyelocele cases.
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Table 3
Associations for maternal periconceptional alcohol consumption and neural tube defects, National Birth 
Defects Prevention Study, 1997–2011
Periconceptional Alcohol 
Consumption
All NTDs combined 
OR (95% CI) Anencephaly
a
 OR (95% 
CI)
Spina Bifida OR 
(95% CI) Encephalocele
b
 OR (95% 
CI)
Any consumption
 None Reference Reference Reference Reference
 Any 0.8 (0.7, 0.9)c 0.6 (0.5, 0.7)c 0.8 (0.7, 0.9)d 0.9 (0.6, 1.2)e
Binge episodes
 None Reference Reference Reference Reference
 No binge episodes 0.7 (0.6, 0.8)c 0.6 (0.5, 0.8)f 0.8 (0.7, 1.0)c 1.0 (0.7, 1.4)e
 One or more binge episodes 0.8 (0.7, 1.0)c 0.7 (0.5, 1.0)f 1.0 (0.8, 1.2)c 0.8 (0.4, 1.2)e
Average number of drinks per 
month
 0 Reference Reference Reference Reference
 1–4
 0.8 (0.7, 0.9)c 0.6 (0.5, 0.8)g 0.9 (0.7, 1.1)c 1.0 (0.7, 1.6)h
 5–15 0.8 (0.7, 0.9)c 0.5 (0.4, 0.8)g 0.9 (0.8, 1.1)c 0.9 (0.5, 1.5)h
 16–30 0.6 (0.5, 0.8)c 0.6 (0.4, 1.1)g 0.6 (0.4, 0.9)c  0.7 (0.3, 1.6)h
 >30 0.8 (0.6, 1.1)c 0.9 (0.4, 1.7)g 0.9 (0.6, 1.3)c 0.9 (0.3, 2.6)h
Type of alcohol
 None Reference Reference Reference Reference
 Beer only
 1.0 (0.8, 1.2)c  0.7 (0.5, 1.0)i  1.1 (0.9, 1.4)j  0.9 (0.5, 1.7)i
 Wine only
 0.6 (0.5, 0.7)c  0.6 (0.4, 0.9)i  0.7 (0.5, 0.9)j  0.7 (0.4, 1.3)i
 Distilled Spirits only
 0.8 (0.7, 1.0)c  0.5 (0.3, 0.9)i  0.9 (0.7, 1.2)j  1.0 (0.6, 1.9)i
 Any combination
 0.7 (0.6, 0.9)c  0.5 (0.4, 0.7)i  0.9 (0.7, 1.1)j  1.0 (0.6, 1.6)i
CI, confidence interval; NTD, neural tube defect; OR, odds ratio.
a
Includes anencephaly and craniorachischisis cases.
b
Includes encephalocele, cranial meningocele, and encephalomyelocele cases.
cAdjusted for NBDPS site.
dCrude OR.
eAdjusted for maternal race/ethnicity and education at delivery.
fAdjusted for NBDPS site, maternal education at delivery, and periconceptional cigarette smoke exposure.
gAdjusted for NBDPS site and maternal periconceptional cigarette smoke exposure.
hAdjusted for NBDPS site, maternal race/ethnicity, and periconceptional cigarette smoke exposure.
iAdjusted for NBDPS site, maternal race/ethnicity, and education at delivery.
jAdjusted for NBDPS site and maternal pre-pregnancy BMI.
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